Page last updated: 2024-10-24
busulfan and Lymphoma, T Cell, Peripheral
busulfan has been researched along with Lymphoma, T Cell, Peripheral in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Jacobsen, ED | 1 |
Kim, HT | 1 |
Jeter, E | 1 |
Jacobson, C | 1 |
Fisher, DC | 1 |
Armand, P | 1 |
Zain, J | 1 |
Palmer, JM | 1 |
Delioukina, M | 1 |
Thomas, S | 1 |
Tsai, NC | 1 |
Nademanee, A | 1 |
Popplewell, L | 1 |
Gaal, K | 1 |
Senitzer, D | 1 |
Kogut, N | 1 |
O'Donnell, M | 1 |
Forman, SJ | 1 |
Ahn, JS | 1 |
Yang, DH | 1 |
Jung, SH | 1 |
Chae, YS | 1 |
Sohn, SK | 1 |
Yhim, HY | 1 |
Kwak, JY | 1 |
Lee, SR | 1 |
Kim, YK | 1 |
Kim, HJ | 1 |
Lee, JJ | 1 |
Other Studies
3 other studies available for busulfan and Lymphoma, T Cell, Peripheral
Article | Year |
---|---|
Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Gemcitabine; Hematopoietic Stem Cell Trans | 2022 |
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosp | 2011 |
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Thera | 2013 |